homozygous NKp46 deficiency resulted in a nearly complete depletion of the ILC1 subset (ILC1) of group 1 ILCs, and heterozygote KO decreased the number of cells in the ILC1 subset. Moreover, transplantation studies confirmed that ILC1 development depends on NKp46 and that the dependency is cell intrinsic. Interestingly, however, the cell depletion specifically occurred in the ILC1 subset but not in the other ILCs, including ILC2s, ILC3s, and NK cells. Thus, our studies reveal that NKp46 selectively participates in the regulation of ILC1 development.
Author summary
Group 1 innate lymphoid cells (ILCs) comprise two subsets: natural killer (NK) cells and ILC1s. Although NK cells and ILC1s are functionally distinct, a factor that regulates one subset but not the other has not been identified. In the current study, we discovered that NKp46, a marker expressed by both NK cells and ILC1s, is critical for the development of ILC1s but not NK cells. In mice lacking NKp46, and in wild-type (WT) mice depleted of immune cells by irradiation and then transplanted with bone marrow (BM) cells lacking NKp46, ILC1s that express cell surface receptor tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) were almost completely absent in all organs or tissues examined, including liver, spleen, BM, and small intestine (SI). In contrast, the cell number and signature cytokine expression of all other ILC subsets-namely NK cells, ILC2s, and ILC3s-were not significantly affected. Collectively, our findings provide new evidence supporting an essential role for NKp46 in the development of ILC1s. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Natural cytotoxicity receptor NKp46, encoded by the Ncr1 gene, is a natural killer (NK) cell-activating receptor that plays roles in regulating the NK cell's clearance of virus and rejection of tumor [1] . Following binding to its putative ligands, the receptor activates intracellular signaling through immune-receptor tyrosine-based activating motifs (ITAMs) [2] . Some non-NK innate lymphoid cell (ILC) populations also express NKp46, including the ILC1 subset (Lin ) of group 3 ILCs [4] . However, the role of NKp46 in these non-NK ILCs is still poorly understood. We previously reported that NKp46 defines a subset of NKT cells susceptible to malignant transformation in the presence of interleukin 15 (IL-15) and has a role in the NK cell clearance of herpes simplex virus 1 [5, 6] . In the current study, we aimed to unravel the role of NKp46 in regulating the development and function of NKp46 + ILCs, especially ILC1s, using a genetic approach.
Results and discussion

ILC1s are absent in NKp46-deficient mice
An NKp46 knockout (KO) mouse model-in which Ncr1, the gene encoding NKp46, was replaced with green fluorescent protein (gfp) (Ncr1 gfp/gfp ) [5, 7] -was used in this study. The development of ILC populations was assessed in different organs and tissues comparing wild-type (WT) (Ncr1 
NKp46
─ population (more than 50%) was observed within the NK1.1 + population in the liver (S1A Fig) , consistent with previous studies [8, 9] . The intensity of CD49a surface expression was higher in the NK1. 
Ncr1 gfp/gfp mice lack tumor necrosis factor (TNF)-related apoptosisinducing ligand (TRAIL) + ILC1s
TNF-related apoptosis-inducing ligand (TRAIL) is a functional protein, selectively expressed on the ILC1 subset, that plays an essential role in mediating the cytotoxicity of this population against target cells through triggering the death receptor-transduced signaling pathway [12] . The expression of TRAIL and lack of CD49b expression can also be used to distinguish ILC1s from NK cells [13] because resting NK cells in WT mice do not express TRAIL, while ILC1s do (Fig 2A, left) . Consistent with the data shown in Fig 1 regarding ILCs was barely detectable in the liver (Fig 2A and 2B ) and other organs (Fig 2C) 
NKp46 deficiency has no substantial adverse effect on ILC2 and ILC3 subsets
Due to our observation that NKp46 deficiency restricted the development of ILC1s, we next set out to test whether this effect also occurred in other ILC subsets. However, using the gating (Fig 4D and 4E) . The moderate increase in the proportion of NK cells could be occurring due to the complete lack of ILC1s among NKp46 + NK1.1 + type I ILCs (Fig 4B top right; Fig 4C bot- tom right). Collectively, these results further confirm that ILC1 development depends on NKp46, and this dependency is cell-intrinsic (Fig 1) .
In conclusion, our findings provide novel evidence that NKp46 plays a critical role in ILC1 development. Previous studies in this area focused on transcriptional control of ILC development. It is known that T-bet and Eomes regulate NK cell development, Gata3 controls ILC2 development, and RORγt defines the ILC3 lineage [15] . Several transcription factors-such as nuclear factor interleukin 3 regulated (Nfil3), runt related transcription factor 3 (Runx3), and T-bet-have been found to control ILC1 development; however, these factors do not play a selective role in determining ILC1 development [15] . That is, these transcription factors have some overlapping roles in several types of ILCs and thus individually cannot determine the fate of ILC1 development. For example, T-bet has been shown to play a role not only in ILC1 development but also in NK cell and ILC3 development [15] . Here, we identified a receptor that selectively determines the developmental fate of ILC1s. Our study also supports the notion that ILC1s and NK cells belong to different lineages, although both belong to group 1 ILCs, and both can produce IFN-γ when activated (e.g., by cytokines). Our study also shows that Ncr1 gfp/gfp mice may serve as a useful animal model for investigating the physiological or pathological functions of ILC1s, given their near-complete absence in various organs, while the development and function of other ILCs are kept nearly intact, with the exception of functions related to NKp46's role in NK cells [7, 16] .
Materials and methods
Ethics statement
All animal experiments were performed according to the protocol (# 2012A00000090), which has been approved by The Ohio State University Institutional Animal Care and Use Committee (IACUC). No human subjects were involved in this study.
Mice
NKp46 KO C57BL/6 mice with Ncr1 replaced with gfp (Ncr1 gfp/gfp ) [5, 7] and their heterozygous littermates (Ncr1 gfp/+ ) were used. NKp46 KO C57BL/6 mice were previously described [7] . Congenic CD45.1 + C57BL/6 mice for transplant experiments were purchased from Jackson Laboratory. All mice used in these studies were 10-12 weeks of age.
Flow cytometric analysis and cell sorting
Cells were labelled with flow antibodies for 15 minutes in the dark in PBS containing 2% BSA. Labelled cells were washed twice and resuspended in PBS containing 2% BSA. The prepared samples were analyzed using an LSR-II flow cytometer (BD Bioscience) or sorted using an Aria II cell sorter (BD Bioscience). Anti-CD19-PeCy7 (561739) ), or a mixture of these 2 types of cells at a ratio of 1:1 (10×10 6 in total) were injected IV into the CD45.1 + congenic recipient mice, which were lethally irradiated (4 cGy twice on the same day) using an X-ray irradiator. The detailed protocol was described in our previous studies [17, 18] . 
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